Cite
HARVARD Citation
Cholon, D. et al. (2016). Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutation. Expert review of precision medicine and drug development. 1 (3), pp. 235-243. [Online].